Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index, and 1 are not checked yet.

Direct effect of GLP-1 infusion on endogenous glucose production in humans

Open access

Abstract

Aims/hypothesis Glucagon-like peptide-1 (GLP-1) lowers glucose levels by potentiating glucose-induced insulin secretion and inhibiting glucagon release. The question of whether GLP-1 exerts direct effects on the liver, independently of the hormonal changes, is controversial. We tested whether an exogenous GLP-1 infusion, designed to achieve physiological postprandial levels, directly affects endogenous glucose production (EGP) under conditions mimicking the fasting state in diabetes.Methods In 14 healthy volunteers, we applied the pancreatic clamp technique, whereby plasma insulin and glucagon levels are clamped using somatostatin and hormone replacement. The clamp was applied in paired, 4 h experiments, during which saline (control) or GLP-1(7-37)amide (0.4 pmol min⁻¹ kg⁻¹) was infused.Results During the control study, plasma insulin and glucagon were maintained at basal levels and plasma C-peptide was suppressed, such that plasma glucose rose to a plateau of ~10.5 mmol/l and tracer-determined EGP increased by ~60%. During GLP-1 infusion at matched plasma glucose levels, the rise of EGP from baseline was fully prevented. Lipolysis (as indexed by NEFA concentrations and tracer-determined glycerol rate of appearance) and substrate utilisation (by indirect calorimetry) were similar between control and GLP-1 infusion.Conclusions/interpretation GLP-1 inhibits EGP under conditions where plasma insulin and glucagon are not allowed to change and glucose concentrations are matched, indicating either a direct effect on hepatocytes or neurally mediated inhibition.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00125-012-2738-3

Cites

32 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 30 references

Cited by

See all 154

Metadata

Authors
Seghieri, M., Rebelos, E., Gastaldelli, A., Astiarraga, B. D., Casolaro, A., Barsotti, E., Pocai, A., Nauck, M., Muscelli, E., & Ferrannini, E.
Affiliations
  • University of Pisa (IT)
  • Istituto di Fisiologia Clinica (IT)
  • Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
  • Diabeteszentrum Bad Lauterberg (DE)
Corresponding author
Ferrannini, E.
Venue
Diabetologia
Published
2012-10-12
Volume
56
Issue
1
Pages
156-161
ISSN
  • 0012-186X (ISSN-L)
  • 1432-0428
OpenAlex
W1978334327
Cited by
143
References
30
Citations by year
2026: 5 · 2025: 3 · 2024: 13 · 2023: 7 · 2022: 8 · 2021: 13 · 2020: 8 · 2019: 13 · 2018: 8 · 2017: 11 · 2016: 15 · 2015: 18 · 2014: 11 · 2013: 10
FWCI
10.01
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Diabetologia (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Keywords
glucagon-like peptide-1, endogenous glucose production, hepatic glucose production, glucagon, fasting state, diabetes mellitus, lipolysis, substrate utilization, hepatocytes
MeSH terms
Adult, Blood Glucose, Calorimetry, Indirect, Fatty Acids, Nonesterified, Female, Gluconeogenesis, Glucose, Glycerol, Humans, Hypoglycemic Agents, Infusions, Intravenous, Lipolysis, Liver, Male, Peptide Fragments, Sympathomimetics, Glucose Clamp Technique, Up-Regulation, Cross-Over Studies, Glucagon-Like Peptide 1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct effect of GLP-1 infusion on endogenous glucose production in humans. https://app.cochat.ai/papers/10.1007/s00125-012-2738-3
The paper
Seghieri, M., Rebelos, E., Gastaldelli, A., Astiarraga, B. D., Casolaro, A., Barsotti, E., Pocai, A., Nauck, M., Muscelli, E., & Ferrannini, E. (2013). Direct effect of GLP-1 infusion on endogenous glucose production in humans. Diabetologia. https://doi.org/10.1007/s00125-012-2738-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.